 |
 |
dear peggy, i have been following levesque for some time now. i had a sham surgery in bombay, so i dont wish to have another one. the interview with levesque is very informative. do you have anything similar? douglas wayy d-1990 Peggy Willocks <[log in to unmask]> wrote: Ray, Greg, and others: It behooves me how something like GDNF or the autologous cells Levesque implanted into Turner get turned around and become "examples of successful stem cell research" using cells other than embryonic. The media just reports what they are told,, which often is half truths - - anything for a sensational story. Ray - I and other members of the Parkinson Pipeline Project have been following Cel-Med for some time. The history of this company's affiliation with Parkinson's research is based on a media story back in 2003??? When Dr. Michel Levesque announced the transplanting of autologous (one's own cells) into the brain of a PWP with 90% improvement. Here's what WAS out there on the company Levesque owned - Celmed BioSciences, which has facilities in Montreal and Los Angeles, is a private company spun off by Theratechnologies In addition to its Theralux(TM)( oncology) program, the Company is evaluating adult neural stems cells for the treatment of Parkinson's disease. (see http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/04-26 -2004/0002159836&EDATE= ) Now the rest of this story is speculation. Dr. Levesque had a conflict of interest by being the Investigating physician in the autologous cell transplant effort, in that he owned the company.. As our interview at Grassroots Connection revealed, Levesque did some fancy steps and received a $4 million upgrade for his lab. From GRC site: "Dr. Lévesque: Since we did this first patient, there was a lot of different advances and questions that were raised by several people at different committees about the behavior of these cells and also the conditions under which we are growing these cells (the FDA also has changed its recommendation to that of GLP, meaning “good level III procedures”, but also to achieve a state of good tissue practice), where the culture rooms that are essentially small incubators, and where procedures are performed in an even more sterile fashion than the operating room. If you can imagine a neonatal unit with these “babies” placed in small incubators—the same thing is done with these adult cells. We have little [laboratory] rooms with specific markers and environment to maintain a constant condition of growth. We are finishing with this, at a cost of $4 million, to achieve this type of environment." For full interview: http://grassrootsconnection.com/levesque_transcript.htm Bottom line, Cel-Med has changed management/owners - the autologous cell transplant trial consisted of only one patient so placebo effect cannot be ruled out - the one patient has turned for the worse - and now Levesque can be found working with oncology (cancer) patients. Is it possible that "money talks?" Peggy ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn